SUBSCRIBE
SUBSCRIBE
News   FDA

Q-Med AB: Q-Med AB’s First Product In The Field Of Body Augmentations, MACROLANE, Approved In Europe

September 12, 2006 | 
1 min read
STOCKHOLM, Sweden--(BUSINESS WIRE)--Sept. 12, 2006--Q-Med's (STO:QMED) product MACROLANE has received a CE certification for the indication concave body deformities.
FDA Approvals Europe
MORE ON THIS TOPIC
Digital compass. Business strategic explorer, Vision crisis, Mission path, Agency creative, Digital strategy, Market decision, Achievement strategy, Financial stock, Company vision concepts
Policy
FDA taps prior knowledge to expedite cell and gene therapy development
June 3, 2026
 · 
12 min read
 · 
BioSpace Editorial Staff
Two man climbing on a rock. Work smart not hard concept. This is a 3d render illustration.
Insights
France’s biotech ambition is strong but its scale-up engine still needs work
June 2, 2026
 · 
3 min read
 · 
Jennifer C. Smith-Parker
Laptop with envelope and document with exclamation mark on screen. Receive notification, alert message, warning, get e-mail, email, spam concepts. Flat design vector illustration
Manufacturing
Cracked gaskets and rust-like residues trigger FDA warning letter to Alchymars
May 29, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Pointing up with fingers number three. Close up, isolated on white background.
Cancer
Replimune gives cancer immunotherapy a third try after FDA leadership shakeup
May 29, 2026
 · 
2 min read
 · 
Tristan Manalac